Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference Yahoo Finance Nawigacja wpisu UHealth Doral Opens, Expanding Academic Medicine in South Florida – news.med.miami.edu Zolbetuximab Approval Paves Way for Precision Medicine in Gastric and GEJ Adenocarcinoma – OncLive
